Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24‐week, randomized, double‐blind, active‐controlled, phase 3 trial.

Autor: Xie, Lingding1 (AUTHOR), Han, Jie2 (AUTHOR), Cheng, Zhifeng3 (AUTHOR), Liu, Dexue4 (AUTHOR), Liu, Jie5 (AUTHOR), Xu, Chunrong6 (AUTHOR), Sun, Wenli7 (AUTHOR), Li, Qingju8 (AUTHOR), Bian, Fang9 (AUTHOR), Zhang, Wei10 (AUTHOR), Chen, Jinyu10 (AUTHOR), Zhu, Qian10 (AUTHOR), Thurber, Tara K.11 (AUTHOR), Lock, J. Paul12 (AUTHOR), Zhang, Bo1 (AUTHOR) drbozhang@yahoo.com
Zdroj: Journal of Diabetes. Apr2024, Vol. 16 Issue 4, p1-13. 13p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje